Photo of Heather Baxter
R South Dakota House · District 34

Rep. Heather Baxter

Compare
Total votes
832
all sessions
Attendance
100%
of floor votes
Higher than 80% of chamber peers
With party
77%
of cast votes
Lower than 87% of chamber peers
Bipartisan score
14%
some cross-party votes
Higher than 85% of chamber peers
Sponsored
280
bills & resolutions
Higher than 93% of chamber peers
Committees
5
assignments
832 roll-call votes

Voting record

Breaks with party 22% of the time

Yea
652
voted in favor
Nay
175
voted against
Absent
0
missed votes
Total cast
832
across all sessions
Crossed party
180
votes against own party
This page
832
matching current filters
Bill
Description
Vote
Result
Tally
Date
HB 1291
amend the process for calculating a school district's general fund base percentage. Against party
Nay
Passed
8–6
Feb 9, 2026
HB 1205
amend the manner of calculating state aid to general and special education funding. Against party
Nay
Passed
8–6
Feb 9, 2026
HB 1180
ensure the validity of non-compete agreements in the context of jointly owned business entities.
Yea
Passed
63–2
Feb 9, 2026
HB 1197
revise a provision related to the venue of adoption proceedings.
Yea
Passed
65–0
Feb 9, 2026
SB 50
update the reference to the Internal Revenue Code to reflect current federal law for the administration of South Dakota Retirement System statutes.
Yea
Passed
65–0
Feb 9, 2026
HB 1215
authorize counties and municipalities to issue a license for a cigar bar.
Yea
Passed
59–6
Feb 9, 2026
HB 1228
provide a stipend to certain members of the National Guard who donate an organ for the purpose of transplantation to another individual.
Yea
Passed
10–1
Feb 9, 2026
HB 1001
provide for prescribed burning of state-owned land by a person owning adjoining land and to declare an emergency.
Yea
Passed
65–0
Feb 9, 2026
HB 1290
amend provisions pertaining to calculating local effort and state aid for general education.
Yea
Passed
14–0
Feb 9, 2026
HB 1099
reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.
Yea
Passed
58–7
Feb 9, 2026
Showing 281 to 290 of 832 votes
Previous 1 … 28 29 30 … 84 Next